366 related articles for article (PubMed ID: 6796194)
1. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
Miller FE; Heffner TG; Kotake C; Seiden LS
Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
Heffner TG; Seiden LS
Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
Erinoff L; MacPhail RC; Heller A; Seiden LS
Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hyperactivity in adult rats induced by neonatal intraventricular 6-hydroxydopamine following pargyline or desmethylimipramine treatment.
Olds ME; Yuwiler A
Psychopharmacology (Berl); 1985; 87(4):484-9. PubMed ID: 3936107
[TBL] [Abstract][Full Text] [Related]
5. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
[TBL] [Abstract][Full Text] [Related]
7. Proposed animal model of attention deficit hyperactivity disorder.
Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW
Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871
[TBL] [Abstract][Full Text] [Related]
8. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
Heffner TG; Seiden LS
Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
Minnema DJ; Rosecrans JA
Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.
Archer T; Palomo T; McArthur R; Fredriksson A
Neurotox Res; 2003; 5(1-2):95-110. PubMed ID: 12832225
[TBL] [Abstract][Full Text] [Related]
11. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.
Itoh K; Fukumori R; Suzuki Y
Life Sci; 1984 Feb; 34(9):827-33. PubMed ID: 6422178
[TBL] [Abstract][Full Text] [Related]
12. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
13. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
Carter CJ; Pycock CJ
Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
[TBL] [Abstract][Full Text] [Related]
14. Infant rat hyperactivity elicited by home cage bedding is unaffected by neonatal telencephalic dopamine or norepinephrine depletion.
Pappas BA; Vickers G; Buxton M; Pusztay W
Pharmacol Biochem Behav; 1982 Jan; 16(1):151-4. PubMed ID: 6799968
[TBL] [Abstract][Full Text] [Related]
15. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
[TBL] [Abstract][Full Text] [Related]
16. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
17. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups.
Concannon JT; Braughler JM; Schechter MD
Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694
[TBL] [Abstract][Full Text] [Related]
18. The effect of water-deprivation on locomotor activity in rats treated with 6-hydroxydopamine.
Seiden LS; Pachman SH; Heffner TG; Shaughnessy RA; Vosmer G
Brain Res; 1985 Jul; 337(2):225-32. PubMed ID: 3928086
[TBL] [Abstract][Full Text] [Related]
19. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].
Ikegami M; Iwasaki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616
[TBL] [Abstract][Full Text] [Related]
20. Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons.
Heffner TG; Heller A; Miller FE; Kotake C; Seiden LS
Brain Res; 1983 Jul; 285(1):29-37. PubMed ID: 6411289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
